75 related articles for article (PubMed ID: 26117042)
1. [Amplification Ex Vivo and Cytocidal Activity of Leukemia Tumor-Associated Antigen-Specific Cytotoxic T Lymphocytes].
Zhang Q; Liu X; Wang XB; Wang J; Li Q; Yang LL; Guo Q
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):814-20. PubMed ID: 26117042
[TBL] [Abstract][Full Text] [Related]
2. [Investigation on specific killing acute leukemia cell reaction of the cytotoxic T lymphocyte induced by dendritic cell pulsed with frozen-thawed antigen].
He B; Qiu G; Xie X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Dec; 21(6):974-8. PubMed ID: 15646345
[TBL] [Abstract][Full Text] [Related]
3. [Ex vivo inducing cultured Epstein-Barr virus specific cytotoxic T lymphocytes and evaluation of their killing effect].
Chen GH; Gu B; Chen F; Wang Y; Qiao M; Liu HW; Feng YF; Dai LJ; Zhu ZL; Wu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1597-601. PubMed ID: 24370055
[TBL] [Abstract][Full Text] [Related]
4. [Specific induction of anti-leukemia effects by umbilical cord cell-derived CD8+ T cytotoxic lymphocytes].
Liu X; Tan H; Wang CY; Huang ZQ; Zhang HZ
Zhonghua Xue Ye Xue Za Zhi; 2006 Jul; 27(7):452-5. PubMed ID: 17147247
[TBL] [Abstract][Full Text] [Related]
5. Differential development of CD4 and CD8 cytotoxic T cells (CTL) in PBMC across the leprosy spectrum; IL-6 with IFN-gamma or IL-2 generate CTL in multibacillary patients.
de la Barrera S; Finiasz DM; Fink S; Valdez R; Bottasso O; Balina LM; Sasiain MC
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):45-55. PubMed ID: 9207753
[TBL] [Abstract][Full Text] [Related]
6. Presence of low dose of fludarabine in cultures blocks regulatory T cell expansion and maintains tumor-specific cytotoxic T lymphocyte activity generated with peripheral blood lymphocytes.
Hegde U; Chhabra A; Chattopadhyay S; Das R; Ray S; Chakraborty NG
Pathobiology; 2008; 75(3):200-8. PubMed ID: 18550918
[TBL] [Abstract][Full Text] [Related]
7. [In vitro anti-tumor effect of CTL induced by HSP70-Id complex-modified dendritic cells].
Wang ZH; Ye Q; Hu ZQ; Ye ZQ; Yu X; Shen GX
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):481-5. PubMed ID: 17147108
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunity.
Xie Y; Bai O; Zhang H; Li W; Xiang J
Cancer Biother Radiopharm; 2010 Feb; 25(1):21-8. PubMed ID: 20187793
[TBL] [Abstract][Full Text] [Related]
9. An engineered anti-idiotypic antibody-derived killer peptide (KP) early activates swine inflammatory monocytes, CD3
Ferrari L; Martelli P; Saleri R; De Angelis E; Ferrarini G; Cavalli V; Passeri B; Bazzoli G; Ogno G; Magliani W; Borghetti P
Comp Immunol Microbiol Infect Dis; 2020 Oct; 72():101523. PubMed ID: 32758800
[TBL] [Abstract][Full Text] [Related]
10. Generation of memory CD4+, CD8+, CD45RO+ and CD16- lymphocytes activated with IL-2, INF-gamma, and TNF-alpha with specific cytotoxicity against autologous cervical cancer cells in a mixed leukocyte-tumour cell culture.
Rangel R; Rocha L; Ramirez JL; Ibarra MJ; Solorza G; Monroy A; Ramirez MA; Herrera A; Weiss-Steider B
Eur Cytokine Netw; 1995; 6(3):195-202. PubMed ID: 8589277
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo induction of anti-leukemia cytotoxic T cell effect by dendritic cells from human umbilical cord blood cell origin.
Tan H; Zeng LJ; Ye X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):472-8. PubMed ID: 15972145
[TBL] [Abstract][Full Text] [Related]
12. Helper T cells against tumor-associated antigens (TAA): preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses.
Fujiwara H; Yoshioka T; Shima J; Kosugi A; Itoh K; Hamaoka T
J Immunol; 1986 Apr; 136(7):2715-9. PubMed ID: 3005417
[TBL] [Abstract][Full Text] [Related]
13. [Anti-leukemia activity of T cells impacted by dendritic cells added with sodium selenite].
Yang L; Liu FQ; Wang JW; Wu YP; Ding J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):892-7. PubMed ID: 18718085
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo specific induction of CD8 positive anti-leukemia cytotoxic lymphocytes from umbilical cord blood.
Tan H; Liu X; Ye X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):129-33. PubMed ID: 17490538
[TBL] [Abstract][Full Text] [Related]
15. [Dendritic cells originated from the peripheral blood in chronic hepatitis B patients can induce specific T cell immune response].
Li RB; Chen HS; Xie Y; Fei R; Cong X; Fan CL; Wang SX; Wei L; Wang Y
Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):588-91. PubMed ID: 14572332
[TBL] [Abstract][Full Text] [Related]
16. Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapy.
von Holzen U; Adamina M; Bolli M; Weber WP; Zajac P; Groeper C; Reschner A; Feder C; Schumacher R; Marti W; Oertli D; Heberer M; Spagnoli GC
Int J Cancer; 2005 Jun; 115(2):248-55. PubMed ID: 15688403
[TBL] [Abstract][Full Text] [Related]
17. [Expansion and function of MHC restricted killer T cells derived from umbilical cord blood].
Ming Y; Zhang HY; Wang Z; Liu XD; Zang CB; Song H; Dai XY; Li D
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):195-201. PubMed ID: 25687072
[TBL] [Abstract][Full Text] [Related]
18. Functional balance between T cell chimeric receptor density and tumor associated antigen density: CTL mediated cytolysis and lymphokine production.
Weijtens ME; Hart EH; Bolhuis RL
Gene Ther; 2000 Jan; 7(1):35-42. PubMed ID: 10680014
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo generation and expansion of anti-tumor cytotoxic T-cell lines derived from patients or their HLA-identical sibling.
Montagna D; Schiavo R; Gibelli N; Pedrazzoli P; Tonelli R; Pagani S; Assirelli E; Locatelli F; Pession A; Fregoni V; Montini E; Da Prada GA; Siena S; Maccario R
Int J Cancer; 2004 May; 110(1):76-86. PubMed ID: 15054871
[TBL] [Abstract][Full Text] [Related]
20. Immune response to Moloney murine leukemia virus nonviral, tumor-associated antigens fails to provide in vivo tumor protection.
Jiang D; Flyer DC
J Immunol; 1992 Feb; 148(3):974-80. PubMed ID: 1730885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]